Using Enstilar® in patients with plaque psoriasis before initiation of phototherapy or systemic therapy
Psoriasis is a chronic inflammatory skin disease and can be classified as ‘mild’, ‘moderate’, or ‘severe’. The management of psoriasis should always be based on its severity and individual patient preferences – it should not be more unpleasant than the disease itself. The two most commonly prescribed classes of topical treatment for psoriasis are vitamin D analogues and topical corticosteroids. In this case study, Dr Tan Wooi Chiang shares his clinical experience treating plaque psoriasis with a combined formulation of betamethasone dipropionate and calcipotriol monohydrate in a single spray foam (Enstilar® Foam, LEO Pharma). 

New Molecule

5 New

New Indication

7 New

New Presentation

1 New

New Brand

15 New

Markings
Shape
Form
Color 1
Color 2
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in